Search - tctmd.com

Displaying 461 - 480 of 851

Sort: Relevancy | Date

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Presenter: Shigeru Saito, Jonathon M. White, Brett Hiendlmayr, MD

June 16, 2017

Presentation TVT 2017

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Presenter: David W.M. Muller, Lars Sondergaard, Peter den Heijer, MD

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots II Techniques to Minimize PPM

Presenter: Ariel Finkelstein

June 16, 2017

Presentation TVT 2017

Evolut R Snapshots I - The New Evolut R PRO System

Presenter: John K. Forrest

June 16, 2017

Presentation TVT 2017

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

Presenter: Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Presenter: Albert Markus Kasel, Thomas Walther, Soundos Moualla, MD

June 15, 2017

Presentation TVT 2017

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Presenter: Ran Kornowski

June 15, 2017

Presentation TVT 2017

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Francesco Maisano

June 15, 2017

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Advertisement

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

TCTMD’s Top 10 Most Popular Stories for July 2017

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Evolut R Snapshots II Techniques to Minimize PPM

Evolut R Snapshots I - The New Evolut R PRO System

The Evolut R TAVR System: A Cool Case, New Technology (Including 34mm), and Clinical Program Updates

TAVR for Pure Aortic Insufficiency (AI) With Prior Ascending Aortic Hemi-shield Repair : Unique Role for EVOLUT-R

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

TAVR in Perspective Evolution, Impact, and Future Expectations

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content